{"symbol": "CYCCP", "companyName": "Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.cyclacel.com", "description": "Cyclacel Pharmaceuticals Inc mainly develops targeted medicines for cancer and other proliferative diseases. The company focuses in hematology and oncology-based development pipeline of novel drug candidates.", "CEO": "Spiro Rombotis", "issueType": "ps", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}